Drug Database
Back to search

Netherlands· NL-cf3fc7ba92b3

Caelyx, 2 mg/ml concentraat voor oplossing voor intraveneuze infusie

A doxorubicin product containing doxorubicinehydrochloride, registered in Netherlands by Baxter Holding B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L01DB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCaelyx, 2 mg/ml concentraat voor oplo…ATCL01DB01REGISTER NO.NL-cf3fc7ba92b3PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about doxorubicinehydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Doxorubicin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01DB01 (doxorubicin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search doxorubicin products by name

Doxorubicin · ATC L01DB01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of doxorubicin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Doxorubicin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$12.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DOXORUBICINEHYDROCHLORIDE
Manufacturer
Baxter Holding B.V.
Country
Netherlands (NL)
ATC code
L01DB01
ATC class
Doxorubicin
Defined daily dose
5 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/96/011

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

775 interactions on record for doxorubicin.

Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check doxorubicin against other medicinesHow interaction checks work

Doxorubicin · interactions on record

775 records

  • 98 severe
  • 383 moderate
  • 29 minor
  • 265 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L01DB01

Doxorubicin, as other registers publish it.

All doxorubicin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e4f7809d-48b6-4e2f-ba64-e80741f3130c
GET /v1/drugs/e4f7809d-48b6-4e2f-ba64-e80741f3130c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/caelyx-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Doxorubicin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70105",
  "excipients": [
    "AMMONIUMSULFAAT (E 517)",
    "CHOLESTEROL",
    "FOSFATIDYLCHOLINE, SOJA, GEHYDREERD",
    "HISTIDINE, (L-)",
    "N-(CARBONYL-METHOXYPOLYETHYLEENGLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE NATRIUM",
    "NATRIUMHYDROXIDE (E 524)",
    "SACCHAROSE",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "DOXORUBICINEHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "1996/06/21",
  "procedure_number": "EMEA/H/C/000089",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/96/011",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about doxorubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console